查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1239511

按类型、应用和最终用户分列的 PCA 泵（自调节镇痛泵）市场：2021-2031 年全球机会分析和行业预测

Patient Controlled Analgesia Pumps Market By Type, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 235 Pages | 商品交期: 2-3个工作天内

价格

2021 年 PCA 泵（自调节镇痛泵）市场规模为 2.7767 亿美元，2022 年至 2031 年復合年增长率为 3.9%，预计 2031 年将达到 4.0789 亿美元

PCA（自控镇痛）是一种有效的疼痛管理技术，可让患者控制疼痛。 这些泵提供阿片类止痛药，例如氢吗啡酮、芬太尼和吗啡。 泵连接到静脉管线 (IV)，这是一根插入静脉的小软管。 通常在按下按钮时给药。 这些泵是将药物以受控量推入患者体内的医疗设备。 止痛泵越来越多地用于医院、疗养院和家庭等临床环境。 用于给药吗啡、芬太尼和氢吗啡酮等药物。 PCA 泵的好处包括安全使用、患者满意度、减少镇静、减少药物剂量以及在泵空时提醒护理团队。

PCA 配备了计算机控制的泵，常用于手术后康復的患者。 它用于术后管理。 这是一种让患者有能力控制疼痛的方法。 PCA 对难以口服药物的患者也有好处。 在某些情况下，患者可以设定自己的剂量并按下按钮给自己额外的剂量。 PCA 药物可以通过多种途径给药，包括口服、静脉内、硬膜外、吸入、喷鼻和透皮。

PCA泵用于治疗急性疼痛、慢性疼痛、手术后疼痛、分娩疼痛等，尤其适用于口服药物给药有困难的患者。 PCA 泵可用于治疗初始住院阿片类药物不足以缓解疼痛的急性疼痛病例。 常见的例子包括烧伤、外伤、胰腺炎和血管闭塞性疼痛危象。

PCA泵全球市场的增长是由于对镇痛泵的需求不断增加，以缓解癌症疼痛、骨科疾病、镰状细胞病等疼痛，以及需要镇痛泵的外科手术数量不断增加。主要原因是增加。 然而，新兴国家缺乏对先进 PCA 泵的了解以及产品批准法规阻碍了市场增长。 相反，对 PCA 泵的需求增加和镇痛泵的技术进步预计将为市场参与者提供有利可图的机会。 由于疾病负担的增加，存在用药错误的可能性。 因此，需要更安全、更高效和标准化的先进递送系统。 此外，先进的 PCA 泵的推出为市场提供了有利可图的增长机会。

老年人口增加、慢性疼痛患病率上升和低成本等因素可能会推动市场发展。 此外，全球越来越多的人因癌症和其他疾病接受手术也可能对市场增长产生积极影响。 癌症、镰状细胞病和整形外科等疾病发病率的增加导致对 PCA 泵的需求增加。 例如，根据美国疾病控制与预防中心 (CDC) 的数据，估计到 2022 年 5 月将有大约 100,000 名美国人患有镰状细胞病。 因此，镰状细胞病患病率的上升增加了对 PCA 泵的吸收，推动了市场增长。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 主要影响因素
    • 主要投资领域
  • 波特的五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 中等强度的竞争
  • 市场动态
    • 司机
      • 慢性疼痛疾病增加
      • 镇痛泵的技术进步
      • 手术次数增加
    • 约束因素
      • 缺乏对镇痛泵的认识
      • 严格的政府法规
    • 机会
      • 新兴国家的有利增长机会
      • 止痛泵的开发
  • 分析 COVID-19 对市场的影响

第 4 章 PCA 泵（自调节镇痛泵）市场，按类型

  • 概览
    • 市场规模和预测
  • 电子和无线
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 机械
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 5 章 PCA 泵（自调节镇痛泵）市场：按应用

  • 概览
    • 市场规模和预测
  • 肿瘤和血液
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 消化系统
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 6 章 PCA 泵（自调节镇痛泵）市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 医院
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 门诊手术中心
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 7 章 PCA 泵（自调节镇痛泵）市场：按地区

  • 概览
    • 市场规模和预测：按地区
  • 北美
    • 主要趋势和机会
    • 市场规模和按类型预测
    • 市场规模和应用预测
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 美国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 加拿大
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 墨西哥
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
  • 欧洲
    • 主要趋势和机会
    • 市场规模和按类型预测
    • 市场规模和应用预测
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 德国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 法国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 英国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 意大利
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 西班牙
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 其他欧洲
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
  • 亚太地区
    • 主要趋势和机会
    • 市场规模和按类型预测
    • 市场规模和应用预测
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 日本
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 中国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 印度
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 澳大利亚
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 韩国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 其他亚太地区
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
  • 拉丁美洲/中东/非洲
    • 主要趋势和机会
    • 市场规模和按类型预测
    • 市场规模和应用预测
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 巴西
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 沙特阿拉伯
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 南非
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测
      • 其他拉丁美洲/中东/非洲
      • 主要市场趋势、增长动力和机遇
      • 市场规模和按类型预测
      • 市场规模和应用预测
      • 最终用户的市场规模和预测

第八章竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 名玩家产品映射
  • 比赛仪表板
  • 竞争热图
  • 2021 年最佳球员排名

第九章公司简介

  • Ace-medical
  • Arcomed AG
  • B. Braun SE
  • Becton, Dickinson and Company
  • Henan Tuoren Medical Device Co., Ltd.
  • ICU Medical, Inc.
  • Micrel Medical Devices SA
  • Fresenius SE and Co. KGaA
  • Changzhou Medical Bioengineering Co., Ltd.
  • SCW Medicath Ltd
Product Code: A13386

The patient controlled analgesia pumps market size valued for $277.67 million in 2021 and is estimated to reach $407.89 million by 2031, exhibiting a CAGR of 3.9% from 2022 to 2031.  

Patient-controlled analgesia (PCA) is an effective pain management technique that offers the patient control over their pain. These pumps deliver opioid painkillers such hydromorphone, fentanyl, and morphine. The pump is attached to an intravenous (IV) line, which is a small, flexible tube inserted into a vein. Normally, this medication is administered when the button is pressed. These pumps are medical devices that deliver the medications into a patient's body in controlled amounts. Analgesic pumps are increasingly used in clinical settings such as hospitals, nursing homes, and in home. The applications of these analgesic pumps for delivery of medications such as morphine, fentanyl and hydromorphone. The PCA pump have the advantages such as safe to use, patient satisfaction, less sedation, reduced medication, and the nursing team is informed by an alert when the pump is empty.

PCA is equipped with a computerized pump, which is often used by patients recovering from surgery. It is employed for post-operative management. It is a method of pain control that provides patients with the power to control their pain. In addition, PCA is beneficial for patients who find difficulty in consuming medication by mouth. In some cases, the dose is set and an additional dose can be administered by patients themselves just by pressing a button. The patient-controlled analgesia can be administered by various routes, including oral, intravenous, epidural, inhaled, nasal spray, and transcutaneous.  

Patient controlled analgesia pumps are used to treat acute, chronic, postoperative, and labor pain, particularly in individuals who are unable to receive oral medications. In cases of acute pain in which the initial opioid dose in urgent care was insufficient to relieve pain thus, patient-controlled analgesia pumps can be useful. Some examples of common cases include burns, trauma, pancreatitis, and vaso-occlusive pain crises. 

The growth of global patient controlled analgesia pumps market is majorly driven by increase in demand for analgesic pumps to relieve the pain such as cancer pain, orthopedic, and sickle cell crises pain, rise in number of surgical procedures which requires the analgesic pumps. However, lack of knowledge regarding advanced patient controlled analgesic pumps in emerging countries and regulations for product approval hinders the market growth. Conversely, increase in demand for patient controlled analgesic pumps and rise in technological advancements in analgesic pumps are anticipated to provide lucrative opportunities to the market players. The possibility of medication errors exists due to increase in disease burden. Thus, there is a need for advanced delivery systems that are safer, more efficient, and standardized. In addition, the introduction of advanced PCA pumps provides the lucrative growth opportunities for the market. 

Factors such as surge in geriatric population, rise in prevalence of chronic pain, and low cost are likely to propel the market. Moreover, rise in the number of individuals undergoing surgeries globally for cancer, or other ailments is likely to have a positive impact on the market growth. Rise in incidence of diseases such as cancer, sickle cell disease, and orthopedics has led to an increase in demand for patient controlled analgesic pump devices. For instance, according to the Centers for Disease Control and Prevention (CDC), estimated that approximately 100,000 Americans affected with sickle cell disease in May 2022. Thus, rise in prevalence of sickle cell disease has increased the uptake for PCA pumps and thus drives the market growth.  

The global patient controlled analgesia pumps market is segmented into type, application, end user, and region. By type, the market is categorized into electronic & wireless and mechanical. On the basis of application, the market is segregated into oncology & hematology, gastroenterology, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major Key players that operate in the global patient controlled analgesia pumps market are: Ace-medical, Arcomed AG, B. Braun SE, Becton, Dickinson and Company, Changzhou Medical Bioengineering Co., Ltd., Fresenius SE and Co. KGaA, Henan Tuoren Medical Device Co., Ltd., ICU Medical, Inc., Micrel Medical Devices SA, SCW Medicath Ltd. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient controlled analgesia pumps market analysis from 2021 to 2031 to identify the prevailing patient controlled analgesia pumps market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the patient controlled analgesia pumps market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global patient controlled analgesia pumps market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Electronic and Wireless
  • Mechanical

By Application

  • Oncology and hematology
  • Gastroenterology
  • Others

By End user

  • Hospitals
  • Ambulatory surgical centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Ace-medical
  • B. Braun SE
  • ICU Medical, Inc.
  • SCW Medicath Ltd
  • Changzhou Medical Bioengineering Co., Ltd.
  • Arcomed AG
  • Becton, Dickinson and Company
  • Henan Tuoren Medical Device Co., Ltd.
  • Fresenius SE and Co. KGaA
  • Micrel Medical Devices SA

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate threat of new entrants
    • 3.3.5. Moderate intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in cases of chronic pain diseases
      • 3.4.1.2. Technological advancements in analgesic pumps
      • 3.4.1.3. Increase in number of surgeries
    • 3.4.2. Restraints
      • 3.4.2.1. Lack of awareness regarding analgesia pumps
      • 3.4.2.2. Stringent government regulations
    • 3.4.3. Opportunities
      • 3.4.3.1. Lucrative growth opportunities in developing countries
      • 3.4.3.2. Development in analgesic pumps
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Electronic and Wireless
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Mechanical
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Oncology and hematology
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Gastroenterology
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Ambulatory surgical centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End user
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by End user
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by End user
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by End user
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End user
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by End user
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by End user
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by End user
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by End user
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by End user
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by End user
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End user
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by End user
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by End user
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by End user
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by End user
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by End user
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Type
      • 7.4.5.6.3. Market size and forecast, by Application
      • 7.4.5.6.4. Market size and forecast, by End user
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End user
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by End user
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by End user
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by End user
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by End user

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Ace-medical
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
  • 9.2. Arcomed AG
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
  • 9.3. B. Braun SE
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Becton, Dickinson and Company
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Henan Tuoren Medical Device Co., Ltd.
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. ICU Medical, Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Micrel Medical Devices SA
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Fresenius SE and Co. KGaA
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. Changzhou Medical Bioengineering Co., Ltd.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. SCW Medicath Ltd
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ELECTRONIC AND WIRELESS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR MECHANICAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ONCOLOGY AND HEMATOLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR GASTROENTEROLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. ACE-MEDICAL: KEY EXECUTIVES
  • TABLE 87. ACE-MEDICAL: COMPANY SNAPSHOT
  • TABLE 88. ACE-MEDICAL: PRODUCT SEGMENTS
  • TABLE 89. ACE-MEDICAL: PRODUCT PORTFOLIO
  • TABLE 90. ARCOMED AG: KEY EXECUTIVES
  • TABLE 91. ARCOMED AG: COMPANY SNAPSHOT
  • TABLE 92. ARCOMED AG: PRODUCT SEGMENTS
  • TABLE 93. ARCOMED AG: PRODUCT PORTFOLIO
  • TABLE 94. B. BRAUN SE: KEY EXECUTIVES
  • TABLE 95. B. BRAUN SE: COMPANY SNAPSHOT
  • TABLE 96. B. BRAUN SE: PRODUCT SEGMENTS
  • TABLE 97. B. BRAUN SE: PRODUCT PORTFOLIO
  • TABLE 98. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 99. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 100. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
  • TABLE 101. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 102. HENAN TUOREN MEDICAL DEVICE CO., LTD.: KEY EXECUTIVES
  • TABLE 103. HENAN TUOREN MEDICAL DEVICE CO., LTD.: COMPANY SNAPSHOT
  • TABLE 104. HENAN TUOREN MEDICAL DEVICE CO., LTD.: PRODUCT SEGMENTS
  • TABLE 105. HENAN TUOREN MEDICAL DEVICE CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 106. ICU MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 107. ICU MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 108. ICU MEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 109. ICU MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 110. ICU MEDICAL, INC.: KEY STRATERGIES
  • TABLE 111. MICREL MEDICAL DEVICES SA: KEY EXECUTIVES
  • TABLE 112. MICREL MEDICAL DEVICES SA: COMPANY SNAPSHOT
  • TABLE 113. MICREL MEDICAL DEVICES SA: PRODUCT SEGMENTS
  • TABLE 114. MICREL MEDICAL DEVICES SA: PRODUCT PORTFOLIO
  • TABLE 115. FRESENIUS SE AND CO. KGAA: KEY EXECUTIVES
  • TABLE 116. FRESENIUS SE AND CO. KGAA: COMPANY SNAPSHOT
  • TABLE 117. FRESENIUS SE AND CO. KGAA: PRODUCT SEGMENTS
  • TABLE 118. FRESENIUS SE AND CO. KGAA: PRODUCT PORTFOLIO
  • TABLE 119. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: KEY EXECUTIVES
  • TABLE 120. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: COMPANY SNAPSHOT
  • TABLE 121. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: PRODUCT SEGMENTS
  • TABLE 122. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 123. SCW MEDICATH LTD: KEY EXECUTIVES
  • TABLE 124. SCW MEDICATH LTD: COMPANY SNAPSHOT
  • TABLE 125. SCW MEDICATH LTD: PRODUCT SEGMENTS
  • TABLE 126. SCW MEDICATH LTD: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN PATIENT CONTROLLED ANALGESIA PUMPS MARKET (2022-2031)
  • FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALPATIENT CONTROLLED ANALGESIA PUMPS MARKET
  • FIGURE 10. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ELECTRONIC AND WIRELESS, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR MECHANICAL, BY COUNTRY 2021-2031(%)
  • FIGURE 13. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ONCOLOGY AND HEMATOLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR GASTROENTEROLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 17. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 21. PATIENT CONTROLLED ANALGESIA PUMPS MARKET BY REGION, 2021
  • FIGURE 22. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 23. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45. COMPETITIVE DASHBOARD
  • FIGURE 46. COMPETITIVE HEATMAP: PATIENT CONTROLLED ANALGESIA PUMPS MARKET
  • FIGURE 47. TOP PLAYER POSITIONING, 2021
  • FIGURE 48. B. BRAUN SE: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 49. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 50. B. BRAUN SE: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 51. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 52. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 53. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 54. ICU MEDICAL, INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 55. ICU MEDICAL, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 56. ICU MEDICAL, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 57. FRESENIUS SE AND CO. KGAA: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 58. FRESENIUS SE AND CO. KGAA: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 59. FRESENIUS SE AND CO. KGAA: REVENUE SHARE BY REGION, 2021 (%)